Market Overview

UPDATE: Bank Of America Reiterates On Universal Health Services On Impressive Beat And Raise

Share:
Related UHS
Companies That Have The Most To Lose If Obamacare Is Repealed
CNBC's List Of 20 Beaten-Up Stocks
I Screened These 340 Mid Cap Stocks So You Don't Have To (Seeking Alpha)

In a report published Friday, Bank of America analyst Kevin Fischbeck reiterated a Buy rating on Universal Health Services (NYSE: UHS), and raised the price target from $106.00 to $113.00.

In the report, Bank of America noted, “EPS of $1.51 beat consensus/our est by $0.26 / $0.16 with $0.09 coming from additional TX reimbursement ($0.06 related to prior period). All Acute segment metrics were impressive and while UHS did not quantify the Reform benefit in the quarter or update the full year Reform outlook, the results suggest that Reform benefits accelerated and the core business was strong as well. UHS raised 2014 EPS guidance by $0.75 to $5.55-5.85.

"After adjusting for the additional TX revs and the Q1 beat, it appears the $0.17 Q2 beat (ex. TX item) is flowing through to 2H14 (2H outlook raised by $0.31). On top of the strong results, UHS doubled its dividend and announced a new share repo (up from prior) indicating a more aggressive deployment of capital. UHS's strong quarters on the heels of HCA's positive preannouncement is another positive sign for the group broadly and strong pysch results are a good data point of ACHC. We are raising our 2014/15/16E EPS to $5.85/$6.39/$6.57 from $5.23/$6.04/$6.27 and raising our PO to $113 from $106.”

Universal Health Services closed on Thursday at $97.54.

Latest Ratings for UHS

DateFirmActionFromTo
Jan 2017PiperJaffrayInitiates Coverage OnNeutral
Dec 2016Raymond JamesDowngradesOutperformMarket Perform
Nov 2016Bank of AmericaDowngradesBuyNeutral

View More Analyst Ratings for UHS
View the Latest Analyst Ratings

Posted-In: Bank of America Kevin FischbeckAnalyst Color Price Target Analyst Ratings

 

Related Articles (UHS)

View Comments and Join the Discussion!